Radionuclide ventriculography

Radionuclide ventriculography
Diagnostics
ICD-9-CM 92.05
MeSH D015635
OPS-301 code 3-704

Radionuclide ventriculography, a type of cardiac ventriculography, is a form of nuclear imaging, where a gamma camera is used to create an image following injection of radioactive material, usually Technetium-99m (99mTc). In radionuclide ventriculography, the radionuclide has the property of circulating through the cardiac chambers, availing for studies of the pumping function of the heart.[1] In contrast, in myocardial perfusion imaging, the radionuclide is taken up by the myocardial cells, making its presence correlating with myocardial perfusion or viability of the cells.[1]

Radionuclide ventriculography is done to evaluate coronary artery disease (CAD), valvular heart disease, congenital heart diseases, cardiomyopathy, and other cardiac disorders.[1] It exposes patients to less radiation than do comparable chest x-ray studies. However, the radioactive material is retained in the patient for several days after the test, during which sophisticated radiation alarms may be triggered, such as in airports.[1] Radionuclide ventriculography has largely been replaced by echocardiography, which is less expensive, does not require radiation exposure, and may measure ejection fractions as accurately.[1]

References

  1. ^ a b c d e Merck manuals > Radionuclide Imaging Last full review/revision May 2009 by Michael J. Shea, MD. Content last modified May 2009

Cardiac ventriculography